Sequana Medical N.V Statistics
Sequana Medical N.V (2SE) Stock Statistics & Valuation Metrics
Total Valuation
Sequana Medical N.V has a market cap or net worth of EUR 47.76M. The enterprise value is EUR 114.92M.
- Market Cap
- EUR 47.76M
- Enterprise Value
- EUR 114.92M
Share Statistics
Sequana Medical N.V has 78,172,035 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 78,172,035
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Sequana Medical N.V’s return on equity (ROE) is 1.01 and return on invested capital (ROIC) is 535.69%.
- Return on Equity (ROE)
- 1.01
- Return on Assets (ROA)
- -4.49
- Return on Invested Capital (ROIC)
- 535.69%
- Return on Capital Employed (ROCE)
- 0.43
- Revenue Per Employee
- 2,208.333
- Profits Per Employee
- -930.29K
- Employee Count
- 48
- Asset Turnover
- 0.01
- Inventory Turnover
- 1.14
Valuation Ratios
The current PE Ratio of Sequana Medical N.V is -4.44. Sequana Medical N.V’s PEG ratio is -1.15.
- PE Ratio
- -4.44
- PS Ratio
- 148.06
- PB Ratio
- -63.45
- Price to FCF
- -4.85
- Price to Operating Cash Flow
- -4.97
- PEG Ratio
- -1.15
Income Statement
In the last 12 months, Sequana Medical N.V had revenue of 106.00K and earned -44.65M in profits. Earnings per share was -1.22.
- Revenue
- 106.00K
- Gross Profit
- -2.22M
- Operating Income
- -18.71M
- Pretax Income
- -44.37M
- Net Income
- -44.65M
- EBITDA
- -17.39M
- Earnings Per Share (EPS)
- -1.22
Cash Flow
In the last 12 months, operating cash flow was -20.23M and capital expenditures -95,005, giving a free cash flow of -20.33M billion.
- Operating Cash Flow
- -20.23M
- Free Cash Flow
- -20.33M
- Free Cash Flow per Share
- -1.24
Dividends & Yields
Sequana Medical N.V pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -24.44%
- Earnings Yield
- -19.46%
Stock Price Statistics
- Beta
- 0.48
- 52-Week Price Change
- -18.08%
- 50-Day Moving Average
- 0.51
- 200-Day Moving Average
- 0.49
- Relative Strength Index (RSI)
- 55.60
- Average Volume (3m)
- ―
Important Dates
Sequana Medical N.V upcoming earnings date is Mar 26, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 27, 2026
- Next Earnings Date
- Mar 26, 2027
- Ex-Dividend Date
- ―
Financial Position
Sequana Medical N.V as a current ratio of 0.12, with Debt / Equity ratio of -90.38%
- Current Ratio
- 0.12
- Quick Ratio
- 0.08
- Debt to Market Cap
- 0.35
- Net Debt to EBITDA
- -2.09
- Interest Coverage Ratio
- -0.71
Taxes
In the past 12 months, Sequana Medical N.V has paid 280.00K in taxes.
- Income Tax
- 280.00K
- Effective Tax Rate
- -0.01
Enterprise Valuation
Sequana Medical N.V EV to EBITDA ratio is -5.40, with an EV/FCF ratio of -3.97.
- EV to Sales
- 76.87
- EV to EBITDA
- -5.40
- EV to Free Cash Flow
- -3.97
- EV to Operating Cash Flow
- -4.04
Balance Sheet
Sequana Medical N.V has EUR 3.81M in cash and marketable securities with EUR 40.11M in debt, giving a net cash position of -EUR 36.30M billion.
- Cash & Marketable Securities
- EUR 3.81M
- Total Debt
- EUR 40.11M
- Net Cash
- -EUR 36.30M
- Net Cash Per Share
- -EUR 0.46
- Tangible Book Value Per Share
- -EUR 1.16
Margins
Gross margin is 77.83%, with operating margin of -3076.52%, and net profit margin of -3334.08%.
- Gross Margin
- 77.83%
- Operating Margin
- -3076.52%
- Pretax Margin
- -3292.17%
- Net Profit Margin
- -3334.08%
- EBITDA Margin
- -3164.05%
- EBIT Margin
- -3196.80%

